When the [Affordable Care Act] passed in June 2010, the Congressional Budget Office projected the budget cost between fiscal 2012 and fiscal 2019 to be $462 billion. By June 2012, the cost for these same years had jumped to $574 billion, an increase of nearly 25 percent. Entire report from the American Action Network.
I’ve been lucky so far throughout Hurricane Sandy; save some spotty electricity, a branch threatening to smash my car and light flooding in my basement there has been no other damage. There are others going through far worse right now due to the hurricane so as a reminder, keep these important safety precautions for medicine [...]
: . , Business Ethics and Leadership Home Beyond Compliance Ethics Codes Workplace Culture Case Studies Decision Making Insights Business Ethics Career Development Leadership Management Quotes , Observations Resources Donate Leadership Insight : The price of greatness is responsibility . Winston Churchill , British prime minister 1874-1965 by Michael Josephson on October 30, 2012 Share : this Share Email Facebook Twitter Print Cancel reply Leave a Comment Name E-mail Website Notify me of follow-up comments by . email Notify me of new posts by . email Previous post : Business Ethics Insight : Compliance Plus . Most organizations of size have compliance programs to assure employees obey laws and keep the company out of trouble . This is essentially a risk management strategy and often does
We are very pleased to feature a guest blog post from Mary Woolley, President and CEO, Research!America, about support for medical innovation and why it is an important issue for the majority of likely voters during this year’s election. Woolley not only heads up Research!America, she is also an elected member of the Institute of [...]
Below is a short Q&A that the Healthcare Leadership Council just posted on the Medicare Part D Open Enrollment process. Given our ongoing focus on Part D and helping seniors access resources to ensure a seamless experience, we are including the Q&A here: Q) What is the best online resource for open enrollment? A) [...]
Yesterday PhRMA sponsored a New England Healthcare Institution (NEHI) roundtable about improving patient adherence to their medication regimens. Having recently struggled with my own flakiness in exactly following my doctor’s orders, as well as dealing with the ensuing poor outcomes, this roundtable particularly held my interest. These NEHI roundtables are being held throughout the year (this was the second [...]
I’ve been reading a series on NPR about the history of polio and how increasing immunization rates around the world are leading to an almost complete eradication of this disease. Yesterday’s NPR post was particularly compelling – it was an account of the long journey the vaccine often takes to reach patients, particularly children, living [...]
Our President and CEO John Castellani was published in the New York Times’ Letters to the Editor this morning, in response to a recent story about compounding pharmacies and drug shortages. Recognizing that space is tight on the Times’ opinion pages, we’ve included the full text of his submitted letter here. In “Lapses at Big [...]
The third-leading cause of death in the U.S. is not nearly as recognizable as it should be, even to those who suffer from the condition. More than 13 million people have been diagnosed with chronic obstructive pulmonary disease (COPD); however, another 12 million people don’t even realize that they have it, according to the National [...]
I’ve been a contributor on our very own blog, the Catalyst, for a year now. I try my best to write interesting blog posts that pertain to the incredible work biopharmaceutical scientists do to help improve patient care in the U.S. and around the world. Blog writing is still somewhat new to me but I [...]
At the heart of any productive relationship or venture is trust. In the biopharmaceutical sector, the integrity of our products, our research – and ultimately the faith that physicians and patients have in medicines – requires trust. And it’s something that must be earned. A blog post in yesterday’s New York Times and a related [...]